trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['gastric', 'trastuzumab deruxtecan', 'rux,(-crux),(-trux)', 'lung', 'breast', 't-dxd']
is trastuzumab deruxtecan (t-dxd) a tumor agnostic drug? t-dxd has shown to be effective in the treatment of breast, gastric, and lung cancer and now it seems to be effective in a number of other cancers, especially in patientives 
Director of the Dx-Rx Institute. Consultancy and research specialized in Companion Diagnostics and Drug-Diagnostic Codevelopment